Sponsor:
Wugen, Inc.
Code:
NCT05674526
Conditions
Colorectal Cancer Metastatic
Squamous Cell Carcinoma of Head and Neck
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
WU-NK-101 - Dose Escalation
Cetuximab - Dose Escalation
WU-NK-101 - Cohort Expansion
Cetuximab - Cohort Expansion
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-01. This information was provided to ClinicalTrials.gov by Wugen, Inc. on 2025-03-25.